Clinical Study of BCG Vaccine for Intradermal Injection

Condition:   Tuberculosis Interventions:   Biological: BCG vaccine 1（0.025mg/0.1ml/person）;   Biological: BCG vaccine 2 （0.05mg/0.1ml/person）;   Biological: BCG vaccine 3（0.075mg/0.1ml/person）;   Biological: BCG vaccine 4 （0.075mg/0.1ml/person）;   Biological: Placebo of BCG vaccine （0.1ml/person） Sponsor:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials